Portal Hypertension and Gastrointestinal Bleeding: Diagnosis, Prevention and Management

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2013 Aug 22

PMID 23964137

Citations 30

Authors

Erwin Biecker

Affiliations

Soon will be listed here.

Abstract

Bleeding from esophageal varices is a life threatening complication of portal hypertension. Primary prevention of bleeding in patients at risk for a first bleeding episode is therefore a major goal. Medical prophylaxis consists of non-selective beta-blockers like propranolol or carvedilol. Variceal endoscopic band ligation is equally effective but procedure related morbidity is a drawback of the method. Therapy of acute bleeding is based on three strategies: vasopressor drugs like terlipressin, antibiotics and endoscopic therapy. In refractory bleeding, self-expandable stents offer an option for bridging to definite treatments like transjugular intrahepatic portosystemic shunt (TIPS). Treatment of bleeding from gastric varices depends on vasopressor drugs and on injection of varices with cyanoacrylate. Strategies for primary or secondary prevention are based on non-selective beta-blockers but data from large clinical trials is lacking. Therapy of refractory bleeding relies on shunt-procedures like TIPS. Bleeding from ectopic varices, portal hypertensive gastropathy and gastric antral vascular ectasia-syndrome is less common. Possible medical and endoscopic treatment options are discussed.

Citing Articles

A survey of emergency medicine physicians' knowledge, attitude, and practice towards esophagogastric variceal bleeding.

Gao Z, Gao Y, Ma S, Zhang T, Wu J, Guo S Int J Emerg Med. 2025; 18(1):54.

PMID: 40082795 PMC: 11905617. DOI: 10.1186/s12245-025-00849-9.

Renal dysfunction contributes to deteriorated survival outcomes in patients with upper and lower gastrointestinal bleeding: insights from a cohort study of 1160 cases.

Simon O, Frim L, Farkas N, Sipos Z, Vorhendi N, Boros E Sci Rep. 2025; 15(1):3781.

PMID: 39885254 PMC: 11782606. DOI: 10.1038/s41598-025-87969-7.

Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation.

Lim J, Kim S, Jo A, Kim J, Han S, Kim T Hepatol Int. 2024; 18(5):1579-1588.

PMID: 39020135 DOI: 10.1007/s12072-024-10710-5.

Outcomes of endoscopic sclerotherapy for jejunal varices at the site of choledochojejunostomy (with video): Three case reports.

Liu J, Wang P, Wang L, Guo J, Zhong N World J Gastroenterol. 2024; 30(14):2059-2067.

PMID: 38681128 PMC: 11045488. DOI: 10.3748/wjg.v30.i14.2059.

Gastric antral vascular ectasia is more frequent in patients with non-alcoholic steatohepatitis-induced cirrhosis.

Cleach A, Villeneuve J, Sylvestre M, Huard G, Giard J, Ditisheim S Can Liver J. 2022; 2(3):84-90.

PMID: 35990220 PMC: 9202753. DOI: 10.3138/canlivj.2018-0021.

References

Abraczinskas D, Ookubo R, Grace N, Groszmann R, Bosch J, Garcia-Tsao G . Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?. Hepatology. 2001; 34(6):1096-102. DOI: 10.1053/jhep.2001.29305. View

Soderlund C, Magnusson I, Torngren S, Lundell L . Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol. 1990; 25(6):622-30. DOI: 10.3109/00365529009095539. View

Gimson A, Westaby D, Hegarty J, Watson A, Williams R . A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology. 1986; 6(3):410-3. DOI: 10.1002/hep.1840060314. View

Lo G, Lai K, Cheng J, Chen M, Huang H, Hsu P . Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000; 32(3):461-5. DOI: 10.1053/jhep.2000.16236. View

Yusoff I, Brennan F, Ormonde D, Laurence B . Argon plasma coagulation for treatment of watermelon stomach. Endoscopy. 2002; 34(5):407-10. DOI: 10.1055/s-2002-25287. View

Colombo M, de Franchis R, Tommasini M, Sangiovanni A, Dioguardi N . Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. Hepatology. 1989; 9(3):433-8. DOI: 10.1002/hep.1840090315. View

Kleber G, Sauerbruch T, Ansari H, Paumgartner G . Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology. 1991; 100(5 Pt 1):1332-7. View

Henderson J, Kutner M, Millikan Jr W, GALAMBOS J, Riepe S, Brooks W . Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med. 1990; 112(4):262-9. DOI: 10.7326/0003-4819-112-4-262. View

Barange K, Peron J, Imani K, Otal P, Payen J, Rousseau H . Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology. 1999; 30(5):1139-43. DOI: 10.1002/hep.510300523. View

10.

Christensen E, Fauerholdt L, Schlichting P, Juhl E, POULSEN H, Tygstrup N . Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology. 1981; 81(5):944-52. View

11.

Gluud L, Krag A . Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev. 2012; (8):CD004544. PMC: 11382336. DOI: 10.1002/14651858.CD004544.pub2. View

12.

Barbara G, De Giorgio R, Salvioli B, Stanghellini V, Corinaldesi R . Unsuccessful octreotide treatment of the watermelon stomach. J Clin Gastroenterol. 1998; 26(4):345-6. DOI: 10.1097/00004836-199806000-00029. View

13.

Feu F, Bordas J, Luca A, Garcia-Pagan J, Escorsell A, Bosch J . Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology. 1993; 18(5):1082-9. View

14.

Manning R . Estrogen/progesterone treatment of diffuse antral vascular ectasia. Am J Gastroenterol. 1995; 90(1):154-6. View

15.

Urata J, Yamashita Y, Tsuchigame T, Hatanaka Y, Matsukawa T, Sumi S . The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol. 1998; 13(10):1061-7. DOI: 10.1111/j.1440-1746.1998.tb00571.x. View

16.

Rimola A, Garcia-Tsao G, Navasa M, Piddock L, Planas R, Bernard B . Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000; 32(1):142-53. DOI: 10.1016/s0168-8278(00)80201-9. View

17.

Feu F, Garcia-Pagan J, Bosch J, Luca A, Teres J, Escorsell A . Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995; 346(8982):1056-9. DOI: 10.1016/s0140-6736(95)91740-3. View

18.

Korula J, BALART L, Radvan G, Zweiban B, Larson A, Kao H . A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology. 1985; 5(4):584-9. DOI: 10.1002/hep.1840050410. View

19.

Rossle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V . Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997; 349(9058):1043-9. DOI: 10.1016/s0140-6736(96)08189-5. View

20.

Evrard S, Dumonceau J, Delhaye M, Golstein P, Deviere J, Le Moine O . Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy. 2003; 35(9):729-35. DOI: 10.1055/s-2003-41581. View